Our findings suggest that NGBR- and HBO1-mediated histone H4 acetylation may be a potential target for preventing the onset and progression of sporadic CCM promoted by CCM1 and CCM2 deficiency. The gene discussed is NUS1; the disease is cerebral cavernous malformation.